Schedule 13G ownership disclosure

CELLECTAR BIOSCIENCES INC

Security class unavailable · CUSIP: 15117F500

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
986,293
Percent of class
9.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001622627-23-000002
Form type
SC 13G/A
Filer
Cellectar Biosciences, Inc.
CIK
CIK 1279704
Filed
Feb 14, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub